Floatz logo

Huaier Granule

Pancreatic Adenocarcinoma

Xi'an Jiaotong UniversityUNKNOWNPhase 4 / ApprovedActive
B
62/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
81/ 100

Competitive context

184 Active assets in the Pancreatic Adenocarcinoma cohort.

Asset / SponsorPhaseRating
Fluorouracilum
Jonsson Comprehensive Cancer Center
Phase 4BBB
Docetaxel
Bristol-Myers Squibb
Phase 2BBB
Irinotecan
Jonsson Comprehensive Cancer Center
Phase 3BB
Xaliplatin
Jonsson Comprehensive Cancer Center
Phase 4BB
Capecitabine
Zhejiang University
Phase 4BB

View all 50 →

Same molecule, other indications

Huaier Granule is also rated in:

hepatocellular carcinomaActive
BBB
Indicative · Phase 4
75 / 100
View asset →
breast carcinomaActive
BB
Indicative · Phase 4
65 / 100
View asset →
malignant pancreatic neoplasmActive
BB
Indicative · Phase 4
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →